Searle Sales Management Report
SALES MANAGEMENT REPORT
By
Sohaib Afzal Rana
Omair Ahmed
Acknowledgement
At first of all we would like to thank Almighty Allah y the blessings of whom we are able to finalize this report. We would also like to acknowledge the efforts of following personnel as their kind coordination and cooperation really enabled us to compile this report.
Tahir Ahmed , GM Sales
Ahmed Bin Qasim – GM Marketing
Athar Iqbal , Group Head Human Resources
We would also like to thank our esteemed instructor Mr. Javed Mehmood who imparts us the core knowledge of Sales Management which is of great help in compiling this report.
Company Introduction
Searle is one of the leading pharmaceutical companies in Pakistan having four state-of the-art manufacturing facilities, two in Karachi and two in Lahore, Pakistan.
Searle Pakistan Limited (SPL) was incorporated in Pakistan as a Private Limited Company on October 5, 1965 as a subsidiary of G.D. Searle & Co., U.S.A. In 1966, Searle Pakistan (Private) Limited acquired a small manufacturing facility in S.I.T.E. and production of Aldactone, Lomotil, Diodoquin, Ovulen, Neomycin Sulphate, Probanthine and Hydryllin, etc. started there. Over the years the operation expanded and during 1984 construction of a new factory started. During the year 1986 manufacturing operations of high quality pharmaceutical products were integrated at the newly built factory at Plot # F-319, S.I.T.E. Area, Karachi, measuring 5.24 acres.
On 29th April 1993, G.D. Searle & Company as part of its global policy, disinvested its shares in Pakistan. On November 14, 1993, the company was converted into a Public Limited Company
As a further milestone, during 1996 Ministry of Health, Islamabad, also allowed the manufacturing of Antibiotic products in a dedicated area constructed within SPL present manufacturing facility where production of some excellent antibiotic drugs is being carried out.
During 1996 SPL also joined a limited group of
By
Sohaib Afzal Rana
Omair Ahmed
Acknowledgement
At first of all we would like to thank Almighty Allah y the blessings of whom we are able to finalize this report. We would also like to acknowledge the efforts of following personnel as their kind coordination and cooperation really enabled us to compile this report.
Tahir Ahmed , GM Sales
Ahmed Bin Qasim – GM Marketing
Athar Iqbal , Group Head Human Resources
We would also like to thank our esteemed instructor Mr. Javed Mehmood who imparts us the core knowledge of Sales Management which is of great help in compiling this report.
Company Introduction
Searle is one of the leading pharmaceutical companies in Pakistan having four state-of the-art manufacturing facilities, two in Karachi and two in Lahore, Pakistan.
Searle Pakistan Limited (SPL) was incorporated in Pakistan as a Private Limited Company on October 5, 1965 as a subsidiary of G.D. Searle & Co., U.S.A. In 1966, Searle Pakistan (Private) Limited acquired a small manufacturing facility in S.I.T.E. and production of Aldactone, Lomotil, Diodoquin, Ovulen, Neomycin Sulphate, Probanthine and Hydryllin, etc. started there. Over the years the operation expanded and during 1984 construction of a new factory started. During the year 1986 manufacturing operations of high quality pharmaceutical products were integrated at the newly built factory at Plot # F-319, S.I.T.E. Area, Karachi, measuring 5.24 acres.
On 29th April 1993, G.D. Searle & Company as part of its global policy, disinvested its shares in Pakistan. On November 14, 1993, the company was converted into a Public Limited Company
As a further milestone, during 1996 Ministry of Health, Islamabad, also allowed the manufacturing of Antibiotic products in a dedicated area constructed within SPL present manufacturing facility where production of some excellent antibiotic drugs is being carried out.
During 1996 SPL also joined a limited group of